Olga Nissan
Founder & CEO
Claimed by owner Protica Bio
Former names:
Immunotherapy-based Diagnostics Platform
Protica Bio
About
Protica Bio combines cutting-edge proteomics and machine learning to improve immunotherapy-based clinical decisions and new drug discoveries, with the goal of creating diagnostic capabilities and elevating the response rate for current and future treatments.
The company is utilizing a proprietary platform developed by a leading expert in the field of mass spectrometry from the Weizmann Institute. In addition to laboratory research, the company integrates deep proteomics with machine learning to create diagnostic capabilities and elevate the response rate for current and future treatments.
The company is utilizing a proprietary platform developed by a leading expert in the field of mass spectrometry from the Weizmann Institute. In addition to laboratory research, the company integrates deep proteomics with machine learning to create diagnostic capabilities and elevate the response rate for current and future treatments.
Employees
Product stage
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
1
Investors
1
News
(0)The Team
(2)
ON
ML
Mor Levy
Senior Scientist
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Private Equity Funding
Undisclosed Round
Undisclosed
Jul 2022
1 Investors
Undisclosed
Media gallery
(0)Locations
Israel
שדרות וולפסון 9, Jerusalem, Israel
Locations
Israel
שדרות וולפסון 9, Jerusalem, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,